Educational information, not medical advice — ask your doctor or midwife.
Pulsatilla 30C is a classical homeopathic remedy derived from the pasque flower (Pulsatilla nigricans), a plant native to European meadows. In homeopathy, the source material is serially diluted and succussed (vigorously shaken) until the final preparation — at 30C — contains no detectable molecules of the original plant. The remedy is prescribed not based on pharmacological activity but on a concept called the 'simillimum': matching the remedy to the full symptom picture of the individual.
Homeopathy holds that extreme dilution with succussion imprints an energetic or informational pattern onto water, which then stimulates the body's own healing response. From a conventional science perspective, no mechanism has been established for 30C preparations, as no molecules of the original substance remain. Practitioners select Pulsatilla based on a characteristic symptom profile — emotional sensitivity, symptoms that shift or wander, discomfort in warm rooms, and a craving for open air — rather than a specific diagnosed disease.
Most commonly available as small lactose or sucrose pellets that dissolve under the tongue. Liquid drops are also available in ethanol-water bases. Some manufacturers offer tablets. All forms are considered equivalent in homeopathic practice.
Pulsatilla was among the first remedies 'proved' (systematically tested on healthy volunteers for symptom production) by Samuel Hahnemann in the 1790s and documented in his Materia Medica Pura. It has since become one of the most frequently prescribed polychrest remedies in classical homeopathy, particularly for women and children. The source plant was historically used as an herbal medicine in Europe for eye complaints, menstrual pain, and headaches — though the herbal form is considered toxic in significant doses.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.